본문으로 건너뛰기
13개 시장 근거 비교

시장 전반에서 화장품 물질 하나 비교

INCI 명칭, 화학명, CAS 또는 EC 번호 하나를 입력하세요. 이 도구는 EU 부속서 근거, 연결된 원료 정체 및 독립된 공식 국가 기록을 하나의 비교로 결합합니다.

로컬 기록이 없는 것은 근거 공백으로 표시되며, 허용이나 안전성에 대한 결론으로 표시되지 않습니다.

정확한 정체 검색

가장 확실한 정체 일치를 위해, 공식 출처에서 제공하는 경우 CAS 또는 EC를 사용하세요.
비교 검색어

PRENOL

시장 데이터세트 13개 중 0개에서 일치하는 규제 근거가 발견되었습니다.

근거가 있는 시장
0
근거 부족
13
국가 기록
0
EU 부속서 기록
0
일치하는 규제 기록이 확인되지 않았습니다. 정확한 CAS, EC 또는 공식 INCI 명칭을 시도해 보세요. 이 결과는 색인된 데이터세트 전반의 근거 공백이며, 해당 물질이 허용되거나 안전하다는 증거가 아닙니다.
혹시 다음을 찾으셨나요 Phenol

확인된 정체 근거

CAS:556-82-1
EC:209-141-4
일치 또는 보고된 명칭 1개
PRENOL

시장별 규제 근거

상태는 데이터세트에서 가장 강하게 일치하는 기록을 나타냅니다. 기록을 열어 정확한 조건과 법적 범위를 검토하세요.

시장결과기록데이터세트 적용 범위다음 조치
European Union
EU
일치하는 항목 없음0
Complete annex dataset
Regulation (EC) 1223/2009 consolidated to 1 May 2026
No annex match only means that these five annexes did not return a match; CosIng identity data and other EU obligations still need review.
Great Britain
GB
일치하는 항목 없음0
Complete consolidated annex dataset
GB retained Regulation 1223/2009 schedules, effective 15 August 2026
No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework.
Canada
CA
일치하는 항목 없음0
Complete Hotlist snapshot
Health Canada Cosmetic Ingredient Hotlist, 13 August 2025
The Hotlist is an administrative compliance tool, not an exhaustive safety approval list.
New Zealand
NZ
일치하는 항목 없음0
Complete schedules dataset
Cosmetic Products Group Standard schedules effective 1 January 2026
The searchable spreadsheet is an aid; the legal Group Standard and incorporated notices remain authoritative.
ASEAN
ASEAN
일치하는 항목 없음0
Complete regional annex dataset
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026
Regional annex coverage does not replace member-state implementation dates, notifications or national deviations.
China
CN
일치하는 항목 없음0
Complete prohibited catalogues plus official-source workflow
NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025
IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately.
Japan
JP
일치하는 항목 없음0
Complete Standards appendices dataset
MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot
The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion.
South Korea
KR
일치하는 항목 없음0
Complete current appendix dataset
MFDS Notice 2026-19, effective 18 March 2026
Korean source wording is canonical and other positive lists/notices may still apply to the formulation.
United States
US
일치하는 항목 없음0
Complete enumerated federal ingredient rules
eCFR Title 21 issue date 27 August 2026
FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety.
Australia
AU
일치하는 항목 없음0
Complete cosmetic-relevant Poisons Standard subset plus official workflow
Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026
An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction.
Brazil
BR
일치하는 항목 없음0
Complete prohibited dataset plus current restricted-list workflow
ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026
RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026.
India
IN
일치하는 항목 없음0
Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)
The standards are separate controlled publications; absence from a locally indexed excerpt is not permission.
Saudi Arabia
SA
일치하는 항목 없음0
Complete official list index
SFDA live prohibited/restricted lists, snapshot 30 August 2026
No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply.
이 필터와 일치하는 시장 행이 없습니다.

공식 확인 절차 완료

원료 근거는 하나의 계층일 뿐입니다. 이 시장별 단계는 규제 준수 판단 전에 남은 확인 사항을 알려 줍니다.

European Union · Complete annex dataset
  1. Confirm the exact INCI/CAS/EC identity.
  2. Review every matching Annex II–VI row and its conditions.
  3. Check SCCS opinions, CMR/nanomaterial rules and later amendments.
  4. Verify product classification, claims, labelling and responsible-person duties.
시장 적용 범위 열기
Great Britain · Complete consolidated annex dataset
  1. Confirm INCI/CAS/EC identity.
  2. Review every current GB Annex II–VI match.
  3. Check commencement dates and later statutory instruments.
  4. Verify SCPN, responsible-person, safety-report and labelling duties.
시장 적용 범위 열기
Canada · Complete Hotlist snapshot
  1. Search English/French names and CAS identifiers.
  2. Apply every restriction, concentration and label warning.
  3. Check Food and Drugs Act/Cosmetic Regulations requirements.
  4. Recheck the current Hotlist before notification or sale.
시장 적용 범위 열기
New Zealand · Complete schedules dataset
  1. Search exact identity across Schedules 4–8.
  2. Apply use, concentration and warning conditions.
  3. Check hazardous-substance classification and Group Standard scope.
  4. Confirm the latest legal instrument, not only the spreadsheet.
시장 적용 범위 열기
ASEAN · Complete regional annex dataset
  1. Search all ACD annexes by name and identifiers.
  2. Apply product type, maximum level and warning conditions.
  3. Confirm the target member state's adoption and transition date.
  4. Complete the local notification and responsible-company requirements.
시장 적용 범위 열기
China · Complete prohibited catalogues plus official-source workflow
  1. Search the current NMPA IECIC List I and List II by Chinese name and identity.
  2. Check prohibited/restricted and positive lists in the current Safety and Technical Standards.
  3. Review technical purpose, use history and any monitoring period.
  4. Confirm Chinese labelling, safety assessment and filing/registration duties.
시장 적용 범위 열기
Japan · Complete Standards appendices dataset
  1. Search Japanese/English identity and CAS where present.
  2. Apply category and maximum-amount conditions.
  3. Check later MHLW notices against the Japanese source.
  4. Verify marketing licence, notification, labelling and quasi-drug classification.
시장 적용 범위 열기
South Korea · Complete current appendix dataset
  1. Match the Korean canonical substance name and identifiers.
  2. Review all Appendix 1 and 2 matches and conditions.
  3. Check functional-cosmetic and positive-list requirements where applicable.
  4. Confirm current MFDS notice, responsible seller and label obligations.
시장 적용 범위 열기
United States · Complete enumerated federal ingredient rules
  1. Search Part 700 and all relevant colour-additive parts.
  2. Confirm colour additive identity, permitted uses, limits and certification status.
  3. Assess safety and adulteration under the FD&C Act.
  4. Complete MoCRA facility/product, adverse-event and label obligations where applicable.
시장 적용 범위 열기
Australia · Complete cosmetic-relevant Poisons Standard subset plus official workflow
  1. Decide whether the product is a cosmetic or therapeutic good.
  2. Check the current Poisons Standard for every ingredient.
  3. Search AICIS Inventory terms and assessment certificates by exact identity.
  4. Determine introduction category, registration, reporting, records and labelling duties.
시장 적용 범위 열기
Brazil · Complete prohibited dataset plus current restricted-list workflow
  1. Resolve Portuguese, INCI and CAS identity with the ANVISA crosswalk.
  2. Check the consolidated prohibited list including RDC 1.030/2026 changes.
  3. Apply RDC 1.029/2026 restrictions and the still-effective complementary rules.
  4. Verify Mercosur incorporation, regularisation, labelling and transition periods.
시장 적용 범위 열기
India · Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4
  1. Confirm product class and current Cosmetics Rules/gazette amendments.
  2. Check all applicable parts of IS 4707 by exact identity.
  3. Apply Schedule S/other finished-product standards where relevant.
  4. Verify licence/import registration, labelling and testing requirements.
시장 적용 범위 열기
Saudi Arabia · Complete official list index
  1. Search names and CAS across both SFDA lists.
  2. Open the cited restricted-entry detail and apply every condition.
  3. Check current SFDA/GSO technical regulations and updates.
  4. Complete eCosma notification, label and responsible-party requirements.
시장 적용 범위 열기

이 비교가 판단할 수 있는 것과 없는 것

1. 정체 확인

CAS 및 EC 토큰은 정확히 추출됩니다. 명칭 검색은 정규화된 공식 명칭과 연결된 정체를 사용합니다.

2. 근거 비교

가장 강하게 일치하는 상태와 직접 기록이 지원되는 모든 시장별로 별도로 표시됩니다.

3. 확인 마무리

제품 유형, 농도, 순도, 경고 문구, 표방, 분류 및 이후 개정에 대해서는 여전히 공식 검토가 필요합니다.